Subject: MJNA Featured in New Interview at

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJNA Featured in New Interview at
Hot Stock to WatchHot Stock to Watch

Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)


Price: 0.1095

Change (%): - 0.002 (1.79)

Volume: 448,735
MJNA Chart

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., Discusses Recent News and Events in a New Audio Interview at

AUSTIN, Texas, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) (the Company) and, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States, is now available. The interview can be heard at

Medical Marijuana, Inc. CEO Dr. Stuart Titus called in to to provide the listening audience with his insights into the drivers behind the Company’s largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway. Dr. Titus also provided updates on several of MJNA’s subsidiaries and its major investment AXIM Biotechnologies, Inc. (OTC:AXIM).

In the interview Dr. Titus stated, “Kannaway has been performing fabulously well throughout the year. They are certainly a big part of our growth in terms of sales. AXIM Biotechnologies (OTC:AXIM), we believe has always held a tremendous amount of promise being one of the premier up and coming biotechnologies companies particularly in the cannabinoid space. We are certainly excited about some of the recent developments with AXIM.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks